These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14091631)

  • 1. [POST-HEPARIN CLEARING FACTOR AND HEPATOPATHIES].
    SALVATORE V; CUCURACHI L; STRATA A; CASTELLO S
    Rass Fisiopatol Clin Ter; 1963; 35():558-76. PubMed ID: 14091631
    [No Abstract]   [Full Text] [Related]  

  • 2. [RETENTION JAUNDICE AND POST-HEPARIN PLASMA CLEARING FACTOR].
    CHARBONNIER A; PHOCAS E
    Epatologia; 1963; 9():568-81. PubMed ID: 14132301
    [No Abstract]   [Full Text] [Related]  

  • 3. TRANSIENT HYPERLIPEMIA FOLLOWING MYOCARDIAL INFARCTION ASSOCIATED WITH INHIBITION OF HEPARIN CLEARING ACTIVITY.
    ELIAKIM M; SHAFRIR E
    Am J Med; 1964 Oct; 37():592-601. PubMed ID: 14215846
    [No Abstract]   [Full Text] [Related]  

  • 4. [ON SOME PROBLEMS REGARDING THE METABOLISM OF LIPIDS IN HEPATOLOGY].
    CACHIN M; CHARBONNIER A
    Epatologia; 1963; 9():507-44. PubMed ID: 14132298
    [No Abstract]   [Full Text] [Related]  

  • 5. [LIPID RESEARCH IN DIABETES].
    BISERTE G; SEZILLE G; BERTRAND M; JAILLARD J
    Ann Biol Clin (Paris); 1964; 22():861-97. PubMed ID: 14189619
    [No Abstract]   [Full Text] [Related]  

  • 6. Demonstration of lipoprotein lipase activity (free fatty acid release) by in vitro sonic oscillation (sonation) of post-heparin plasma from subjects with "heparin-unresponsive" hyperglyceridemia (hyperlipemia).
    FURMAN RH; ROBINSON CW
    Trans Am Clin Climatol Assoc; 1961; 73():30-8. PubMed ID: 13895954
    [No Abstract]   [Full Text] [Related]  

  • 7. LIPOLYTIC ACTIVITY AND PLASMA-FREE FATTY ACID LEVELS FOLLOWING THE ADMINISTRATON OF AN INHIBITOR OF THE CLEARING REACTION.
    HOLLETT CR
    Biochim Biophys Acta; 1965 Feb; 98():61-5. PubMed ID: 14290839
    [No Abstract]   [Full Text] [Related]  

  • 8. STUDIES OF THE INFLUENCE OF DIET ON CLEARING-FACTOR LIPASE (CFL) AND BLOOD LIPID LEVELS OF A PATIENT WITH HYPERLIPIDEMIA.
    MACNAB M; MACMILLAN RL; MONKHOUSE FC
    Can Med Assoc J; 1965 Jan; 92(5):217-20. PubMed ID: 14246294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nmn-esterified fatty acids and lipoprotein lipase activity in patients with cirrhosis of the liver.
    CHLOUVERAKIS C; HARRIS P
    Gut; 1961 Sep; 2(3):233-9. PubMed ID: 13879081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HEPARIN AND THE ELECTROPHORETIC MOBILITY OF BETA-LIPOPROTEIN IN CORONARY DISEASE.
    GROVER ME
    Am J Cardiol; 1965 Jan; 15():13-6. PubMed ID: 14248273
    [No Abstract]   [Full Text] [Related]  

  • 11. [On lipoprotein lipase activity, serum lipids and the effect of heparin on the blood sugar level in atrophic liver cirrhosis and chronic hepatitis].
    Bosadjiewa E; Warbanow G; Markowski S; Beltschew L; Russinow E
    Z Gesamte Inn Med; 1967 Jul; 22(13):393-6. PubMed ID: 5595619
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study of various drugs and their action on lipids and the clearing factor].
    MOSSO HE; PERGOLA F; KATZ S
    Dia Med; 1962 Mar; 34():330-4. PubMed ID: 14476562
    [No Abstract]   [Full Text] [Related]  

  • 13. [Deviations in the level of serum lipids and higher fatty acids in liver cirrhosis and chronic hepatitis].
    Koĭchev K; Vurbanov G
    Vutr Boles; 1977; 16(2):65-71. PubMed ID: 878449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LIPID METABOLISM AND THE LAYING HEN. 3. PLASMA LIPOPROTEIN LIPASE IN RELATION TO THE ONSET OF LAYING.
    HEALD PJ; FURNIVAL BM; ROOKLEDGE KA
    Biochim Biophys Acta; 1965 Feb; 98():66-72. PubMed ID: 14290840
    [No Abstract]   [Full Text] [Related]  

  • 15. [EXPERIENCES WITH A SIMPLE BETA-LIPOPROTEIN DETERMINATION. 1. BETA-LIPO-PROTEINS IN CHRONIC LIVER DISEASES].
    LINK J; FASSATI P
    Z Gesamte Inn Med; 1964 May; 19():400-2. PubMed ID: 14237329
    [No Abstract]   [Full Text] [Related]  

  • 16. [INFLUENCE OF ORAL LIPID ADMINISTRATION ON THE POST-HEPARIN "CLEARING" AND "LIPOLYTIC" POWER IN HEALTHY YOUNG PERSONS AND IN AGED ARTERIOSCLEROTIC PATIENTS].
    CONCONI F; MANENTI F; TORRI A; NAVA C
    Acta Vitaminol; 1964 Feb; 18():13-21. PubMed ID: 14157826
    [No Abstract]   [Full Text] [Related]  

  • 17. [EFFECTS OF BETA-SITOSTEROL ON THE BLOOD LEVEL OF CHOLESTEROL, LIPIDS AND POLYUNSATURATED FATTY ACIDS (CLINICAL STUDY)].
    DIPAOLO E
    Arch Patol Clin Med; 1963 Nov; 40():211-24. PubMed ID: 14116204
    [No Abstract]   [Full Text] [Related]  

  • 18. AN INVESTIGATION OF ROUTES OF ADMINISTRATION OF HEPARIN OTHER THAN INJECTION.
    WINDSOR E; FREEMAN L
    Am J Med; 1964 Sep; 37():408-16. PubMed ID: 14209287
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fatty acids in lipid fractions of blood serum in patients with chronic liver diseases].
    Markova MN; Loginov AS
    Ter Arkh; 1975; 47(2):84-92. PubMed ID: 1145465
    [No Abstract]   [Full Text] [Related]  

  • 20. THE EFFECT OF HEPARIN PRETREATMENT ON DEVELOPMENT AND CLEARING OF ALIMENTARY LIPEMIA.
    Barboriak JJ; Kory RC; Chamilton LH
    Am J Clin Nutr; 1965 May; 16():412-6. PubMed ID: 14286798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.